An estimated 170 million persons are infected with the hepatitis C virus (HCV) worldwide.
While hepatocytes are the major site of infection, a broad clinical spectrum of extrahepatic …

Interferon alpha (IFNα) is the cornerstone therapeutic agent for chronic hepatitis C virus
(HCV) infection. Prospective studies have shown that up to 15% of HCV patients receiving …

Autoimmune thyroid diseases (AITDs), including Graves' disease (GD) and Hashimoto's
thyroiditis (HT) are prevalent autoimmune diseases, affecting up to 5% of the general …

Non-insulin-dependent diabetes mellitus (NIDDM) may be associated with chronic hepatitis
C virus (HCV) infection. This was studied further in two parts. First, 1,151 patients with HCV …

Hepatitis C virus (HCV), a major cause of liver disease worldwide, is frequently resistant to
the antiviral alpha interferon (IFN). The HCV nonstructural 5A (NS5A) protein has been …

It is unclear whether the current antiviral treatment for chronic hepatitis C virus (HCV)
infection results in complete elimination of the virus, or whether small quantities of virus …

Background. Recent studies suggest an association between diabetes mellitus and hepatitis
C virus (HCV) infection. Our aim was to determine (1) the prevalence and determinants of …

Reports of cerebral dysfunction in chronic hepatitis C virus (HCV) infection have led to the
suggestion that HCV may infect the central nervous system (CNS). We used reverse …

Hepatitis C virus (HCV) infection has a detrimental role on patient and graft survival after
renal transplantation (RT). Some studies have also implicated HCV in the development of …

OBJECTIVE: The objective of the study was to determine the effect of hepatitis C virus (HCV)
on selected maternal and infant birth outcomes. STUDY DESIGN: This population-based …